House Hearing Puts Hospital CEOs on the Spot Over Exorbitant Charges

During a recent House hearing conducted by the Ways and Means Committee, hospital CEOs were put on the spot over the inexplicably high facility fees that they charge. GOP members of the committee accused the hospitals of taking advantage of the healthcare system and of overcharging patients. 

The hospital executives who attended the hearing included those from CommonSpirit Health, HCA Healthcare, ECU Health and New York Presbyterian. 

Approximately $1.6 trillion of the money spent on healthcare in 2024 went to hospitals, and this was approximately 33% of the total amount that went to healthcare in that year. The executives asserted that it was within their rights to levy higher fees when compared to the fees levied by independent medical practices. 

According to research, patients often pay more when they visit a doctor that is part of a hospital network when compared to seeking the same service at a private doctor’s practice. Hospital networks charge higher for the same service, and the committee found this to be unacceptable. 

Of special concern to the committee were the “facility fees” levied by hospitals. The Congressmen wondered how those fees could be justified and yet they have no connection to the specific medical care that a patient seeks at the facility linked to a hospital. Hospital executives claimed those facility fees help them to meet the cost of equipment and paying staff. 

Several lawmakers provided examples of such high fees levied within their states. For example, Representative David Kustoff, a Republican from Tennessee, cited an independent surgical center in his state that charges a $656 facility fee on patients that need a colonoscopy. In contrast, an outpatient facility linked to a hospital in the state charges a facility fee of $1,222. This huge difference was unreasonable, the legislator argued. 

The CEOs responded that their facility fees are higher partly because the reimbursement they receive for providing care is often below what providing that care costs the hospital. They cited Medicaid and Medicare as major programs under which reimbursements are lower than what is spent to extend the needed care. 

The other reasons they gave to explain their higher fees included their claim that they handle sicker patients, provide care of higher quality and are required by federal regulations to attend to all patients regardless of whether those patients have the ability to pay for the cost of that care. They said independent medical facilities are free to choose which patients they serve and which ones they turn away, and that causes disparities in the total costs incurred. 

Notably, Democrats on the committee were largely silent and instead said the GOP was trying to detract from their policy issues, such as Medicaid funding cuts that are increasing healthcare costs around the country. 

It remains to be seen whether meaningful reforms will result from this hearing. What isn’t in question is the reality that providers of healthcare insurance coverage, such as Astiva Health, have to contend with the high hospital fees levied and inevitably pass these on to policyholders. 

About BioMedWire

BioMedWire (“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled recognition and brand awareness.

BMW is where breaking news, insightful content and actionable information converge.

To receive SMS alerts from BioMedWire, “Biotech” to 888-902-4192 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: https://www.BioMedWire.com/Disclaimer

BioMedWire
Austin, Texas
www.BioMedWire.com
512.354.7000 Office
Editor@BioMedWire.com

BioMedWire is powered by IBN